Mayor of Moscow Sergey Sobyanin and rector of MSU Viktor Sadovnichy opened on Tuesday, April 21, a coronavirus hospital located on the premises of the University Clinic - the Medical Research and Educational Center of MSU on Lomonosovsky Prospekt.
“I acted in cooperation with Viktor Antonovich to ensure supplies of process equipment, therefore the MSU Clinic is one of the best in terms of infrastructure and equipment,” said mayor of Moscow Sergey Sobyanin.
The MSU Clinic was transformed into a hospital to treat coronavirus patients, which made it possible to accommodate 100 beds for patients sick with coronavirus and 24 critical care beds. The in-patient facility boasts state-of-the-art medical equipment, including two CT scanners, one MRI scanner, 16 ventilators and 22 anaesthetic and respiratory apparatuses.
“We are receiving more and more reports fr om various physicians who share their successful experience of using our products, adsorption columns. The core of our team is made up of graduates of Moscow State University, and our company is a resident of the MSU Science Park, that is why it is especially difficult for us to stand on the sidelines. We joined efforts with our partners from NANOLEK to deliver a batch of devices to the University clinic for free, and I hope that this will help preserve people’s health,” commented Ivan Bessonov, co-founder and Technical Director of Efferon, on his decision.
Earlier, Nanolek and Efferon also donated adsorption columns to the state budgetary healthcare institution of Moscow “City clinical hospital No. 40” in Kommunarka that treats patients with a new coronavirus infection.
“We are glad that medical devices developed by residents of the MSU Science Park in partnership with scientists of MSU will help in the fight against complications following coronavirus infection,” said Maxim Stetsyuk, Executive Director of NANOLEK.
Background information
Efferon JSC is a resident of the Science Park of Lomonosov Moscow State University and Skolkovo Foundation. The company produces adsorption columns “Efferon CT” and “Efferon LPS”.
Nanolek LLC is a Russian biopharmaceutical company with its own high-tech full-cycle production according to GMP standards, which specializes in the production of vaccines, drugs for the treatment of HIV, cancer and other diseases.
The first device - “Efferon CT” - is intended to treat acute respiratory distress syndrome (severe lung damage in patients with pneumonia). The second column — “Efferon LPS” - can be used to purify blood in sepsis which can develop in a weakened body during long-term treatment and in cases wh ere artificial ventilation (ventilators) is used.